IP Verse

Lek Pharmaceuticals D.d. competitive analysis

Latest oppositions filed by Lek Pharmaceuticals D.d.

Explore patent oppositions filed by Lek Pharmaceuticals D.d. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP4233850
Capsule FormulationsCHEMOCENTRYXJun 12, 2025
EP3886820
Capsule FormulationsCHEMOCENTRYXJan 12, 2024
EP2451445
Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active IngredientBOEHRINGER INGELHEIMDec 20, 2019
EP3078667
Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICAAug 14, 2019
EP2568988
Pharmaceutical Formulations Comprising 1 - (Beta-D-Glucopyranosyl) - 2 -Thienylmethylbenzene Derivatives As Inhibitors Of SgltJANSSEN PHARMACEUTICAApr 13, 2017
EP1989182
Crystalline Form Of The Arginine Salt Of Perindopril, Process For Preparing It, And Pharmaceutical Compositions Comprising ItLES LABORATOIRES SERVIERJan 12, 2017
EP2251344
Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICADec 23, 2016
EP2508521
Method For The Production Of Amino Crotonyl CompoundsBOEHRINGER INGELHEIMSep 30, 2016
EP2538925
Apixaban FormulationsBRISTOL MYERS SQUIBBSep 16, 2016
EP2550286
Crystalline Forms Of A Macrolide, And Uses ThereforCEMPRA PHARMACEUTICALSSep 9, 2016

Latest patents of Lek Pharmaceuticals D.d. opposed by its competitors

Explore Lek Pharmaceuticals D.d.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2755957
May 15, 2019Synthesis Of Triazolopyrimidine Compounds1
EP2981520
Mar 6, 2019New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine2
EP2697251
Feb 27, 2019A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant Proteins4
EP1915349
Sep 12, 2018Process For Preparing Pure Amorphous Rosuvastatin Calcium2
EP2501799
Jan 24, 2018Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content2
EP1771455
May 11, 2016Oxidative Degradation Products Of Atorvastatin Calcium1
EP2269583
Aug 13, 2014Pharmaceutical Composition Comprising Hydrochlorothiazide And Telmisartan1

Latest PTAB cases involving Lek Pharmaceuticals D.d.

Discover the latest PTAB cases involving Lek Pharmaceuticals D.d., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lek Pharmaceuticals D.d. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LEK PHARMACEUTICALS DD1613 - -
BOEHRINGER INGELHEIM4523289
BRISTOL MYERS SQUIBB6124 - 8
CHEMOCENTRYX13 - -